Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation

Khalid M El-Say,1,2 Osama AA Ahmed,1,3 Amir I Mohamed,4 Martin K Safo,5 Abdelsattar M Omar6,7 1Nanotechnology Laboratory, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: El-Say KM, Ahmed OAA, Mohamed AI, Safo MK, Omar AM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/aff61fcf440b43c1ac884cc6ba370ccd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aff61fcf440b43c1ac884cc6ba370ccd
record_format dspace
spelling oai:doaj.org-article:aff61fcf440b43c1ac884cc6ba370ccd2021-12-02T09:44:29ZZein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation1178-2013https://doaj.org/article/aff61fcf440b43c1ac884cc6ba370ccd2019-09-01T00:00:00Zhttps://www.dovepress.com/zein-alpha-lipoic-acid-loaded-nanoparticles-to-enhance-the-oral-bioava-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Khalid M El-Say,1,2 Osama AA Ahmed,1,3 Amir I Mohamed,4 Martin K Safo,5 Abdelsattar M Omar6,7 1Nanotechnology Laboratory, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Military Medical Academy, Cairo, Egypt; 5Department of Medicinal Chemistry, and the Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; 6Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; 7Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, EgyptCorrespondence: Khalid M El-SayPharmaceutics and Industrial Pharmacy, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, P.O. Box: 80260, Jeddah, Saudi ArabiaTel +966 126 400 0002 0073Fax +966 12 695 1696Email kelsay1@kau.edu.saBackground: Premature ejaculation (PE) is the most common type of male sexual disorder with important psychological consequences. Dapoxetine (DPX), a recently approved drug for the treatment of PE, suffers from low bioavailability with large variability that ranges from 15–76% (mean 42%) after oral administration. The objective of this study is to optimize the parameters for the preparation of DPX-Zein-alpha lipoic acid (ALA) nanoparticles (NPs) to improve the bioavailability of DPX and consequently decrease therapeutic dose and adverse effect, leading to patient satisfaction and compliance.Methods: We investigated the effect of ALA concentration, PVA concentration and stirring rate on nanoparticle size (Y1), zeta potential (Y2), initial DPX release (Y3) and cumulative DPX release (Y4). In addition, in vivo pharmacokinetic study was performed for the optimized DPX formulation on human healthy volunteers compared with marketed DPX tablet.Results: The optimized DPX-loaded NPs showed Y1, Y2, Y3, and Y4 of 159.24 nm, 19.14 mV, 25.31% and 95.9 %, respectively. A single oral dose of 30 mg of optimized DPX-loaded NPs to human volunteers resulted in 2-fold improvement of AUC (1376.145±339.592 vs 709.178±146.307 in DPX), 4-fold increase in tmax (2.5±0.314 vs 0.583±0.144), prolongation of MRT (7.637±1.373 compared to 6.031±1.826 h), but with reduction in t1/2 (5.283±1.077 vs 8.452±2.813).Conclusion: The clinical findings suggest 194% enhancement of relative bioavailability of the optimized DPX-loaded NPs, potentially leading to a decrease in therapeutic dose and associated side effects in the treatment of PE.Keywords: dapoxetine, premature ejaculation, mathematical experimental design, nanoparticles, clinical pharmacokinetics, bioavailabilityEl-Say KMAhmed OAAMohamed AISafo MKOmar AMDove Medical PressarticleDapoxetinepremature ejaculationmathematical experimental designnanoparticlesclinical pharmacokineticsbioavailability.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7461-7473 (2019)
institution DOAJ
collection DOAJ
language EN
topic Dapoxetine
premature ejaculation
mathematical experimental design
nanoparticles
clinical pharmacokinetics
bioavailability.
Medicine (General)
R5-920
spellingShingle Dapoxetine
premature ejaculation
mathematical experimental design
nanoparticles
clinical pharmacokinetics
bioavailability.
Medicine (General)
R5-920
El-Say KM
Ahmed OAA
Mohamed AI
Safo MK
Omar AM
Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
description Khalid M El-Say,1,2 Osama AA Ahmed,1,3 Amir I Mohamed,4 Martin K Safo,5 Abdelsattar M Omar6,7 1Nanotechnology Laboratory, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Military Medical Academy, Cairo, Egypt; 5Department of Medicinal Chemistry, and the Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; 6Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; 7Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, EgyptCorrespondence: Khalid M El-SayPharmaceutics and Industrial Pharmacy, Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, P.O. Box: 80260, Jeddah, Saudi ArabiaTel +966 126 400 0002 0073Fax +966 12 695 1696Email kelsay1@kau.edu.saBackground: Premature ejaculation (PE) is the most common type of male sexual disorder with important psychological consequences. Dapoxetine (DPX), a recently approved drug for the treatment of PE, suffers from low bioavailability with large variability that ranges from 15–76% (mean 42%) after oral administration. The objective of this study is to optimize the parameters for the preparation of DPX-Zein-alpha lipoic acid (ALA) nanoparticles (NPs) to improve the bioavailability of DPX and consequently decrease therapeutic dose and adverse effect, leading to patient satisfaction and compliance.Methods: We investigated the effect of ALA concentration, PVA concentration and stirring rate on nanoparticle size (Y1), zeta potential (Y2), initial DPX release (Y3) and cumulative DPX release (Y4). In addition, in vivo pharmacokinetic study was performed for the optimized DPX formulation on human healthy volunteers compared with marketed DPX tablet.Results: The optimized DPX-loaded NPs showed Y1, Y2, Y3, and Y4 of 159.24 nm, 19.14 mV, 25.31% and 95.9 %, respectively. A single oral dose of 30 mg of optimized DPX-loaded NPs to human volunteers resulted in 2-fold improvement of AUC (1376.145±339.592 vs 709.178±146.307 in DPX), 4-fold increase in tmax (2.5±0.314 vs 0.583±0.144), prolongation of MRT (7.637±1.373 compared to 6.031±1.826 h), but with reduction in t1/2 (5.283±1.077 vs 8.452±2.813).Conclusion: The clinical findings suggest 194% enhancement of relative bioavailability of the optimized DPX-loaded NPs, potentially leading to a decrease in therapeutic dose and associated side effects in the treatment of PE.Keywords: dapoxetine, premature ejaculation, mathematical experimental design, nanoparticles, clinical pharmacokinetics, bioavailability
format article
author El-Say KM
Ahmed OAA
Mohamed AI
Safo MK
Omar AM
author_facet El-Say KM
Ahmed OAA
Mohamed AI
Safo MK
Omar AM
author_sort El-Say KM
title Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
title_short Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
title_full Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
title_fullStr Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
title_full_unstemmed Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
title_sort zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/aff61fcf440b43c1ac884cc6ba370ccd
work_keys_str_mv AT elsaykm zeinalphalipoicacidloadednanoparticlestoenhancetheoralbioavailabilityofdapoxetineoptimizationandclinicalpharmacokineticevaluation
AT ahmedoaa zeinalphalipoicacidloadednanoparticlestoenhancetheoralbioavailabilityofdapoxetineoptimizationandclinicalpharmacokineticevaluation
AT mohamedai zeinalphalipoicacidloadednanoparticlestoenhancetheoralbioavailabilityofdapoxetineoptimizationandclinicalpharmacokineticevaluation
AT safomk zeinalphalipoicacidloadednanoparticlestoenhancetheoralbioavailabilityofdapoxetineoptimizationandclinicalpharmacokineticevaluation
AT omaram zeinalphalipoicacidloadednanoparticlestoenhancetheoralbioavailabilityofdapoxetineoptimizationandclinicalpharmacokineticevaluation
_version_ 1718398027042914304